Back
Immuneering Stock Price Chart
Sponsored
IMRX
Sponsored
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
48
IMRX
Immuneering
Last Price:
$2.22
Seasonality Move:
-14.17%
7 Day Trial
ALL ACCESS PASS
$
7
Elon Musk Predicts MAJOR Crisis in Trump's First Year
See Why Investors are Pouring Mountains of Cash into Certain Companies Trump Wants to Solve the Problem.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IMRX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Immuneering Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.84 | Buy |
20-day SMA: | 2.02 | Buy |
50-day SMA: | 2.01 | Buy |
200-day SMA: | 1.82 | Buy |
8-day EMA: | 1.95 | Buy |
20-day EMA: | 1.97 | Buy |
50-day EMA: | 1.99 | Buy |
200-day EMA: | 2.58 | Sell |
Immuneering Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.03 | Sell |
Relative Strength Index (14 RSI): | 57.61 | Buy |
Chaikin Money Flow: | 427000 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.84 - 2.2) | Buy |
Bollinger Bands (100): | (1.34 - 2.4) | Buy |
Immuneering Technical Analysis
Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Immuneering Stock
Is Immuneering Stock a Buy?
-
Immuneering share price is 2.20 while IMRX 8-day simple moving average is 1.84, which is a Buy signal.
-
The stock price of IMRX is 2.20 while Immuneering 20-day SMA is 2.02, which makes it a Buy.
-
Immuneering 50-day simple moving average is 2.01 while IMRX share price is 2.20, making it a Buy technically.
-
IMRX stock price is 2.20 and Immuneering 200-day simple moving average is 1.82, creating a Buy signal.
IMRX Technical Analysis vs Fundamental Analysis
Sell
48
Immuneering (IMRX)
is a Sell
Is Immuneering a Buy or a Sell?
-
Immuneering stock is rated a SellThe current Immuneering [IMRX] share price is $2.20. The Score for IMRX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
Immuneering Stock Info
Market Cap:
68.3M
Price in USD:
2.20
Share Volume:
597.8K
Immuneering 52-Week Range
52-Week High:
7.92
52-Week Low:
1.00
Sell
48
Immuneering (IMRX)
is a Sell
Immuneering Share Price Forecast
-
What is the Immuneering stock price today?The Immuneering stock price is 2.20 USD today.
-
Will IMRX stock go up or go down?Immuneering> share price is forecast to RISE/FALL based on technical indicators
-
Is Immuneering overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Immuneering is overvalued.
Is Immuneering Stock a Buy?
-
Immuneering share price is 2.20 while IMRX 8-day exponential moving average is 1.95, which is a Buy signal.
-
The stock price of IMRX is 2.20 while Immuneering 20-day EMA is 1.97, which makes it a Buy.
-
Immuneering 50-day exponential moving average is 1.99 while IMRX share price is 2.20, making it a Buy technically.
-
IMRX stock price is 2.20 and Immuneering 200-day simple moving average is 2.58, creating a Sell signal.
Fundamental Analysis of Immuneering
Is Immuneering a good investment?
-
Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and an increase next year of $0.17 per share.
Technical Analysis of Immuneering
Should I short Immuneering stock?
-
IMRX Moving Average Covergence Divergence (MACD) indicator is -0.03, suggesting Immuneering is a Sell
-
Immuneering Relative Strength Index (RSI) is 57.61, which suggest Immuneering is overbought
-
The Bollinger Bands (25) for Immuneering is (1.84 - 2.2), which suggest Immuneering is a Buy
-
The Bollinger Bands (100) for Immuneering is (1.34 - 2.4), which suggest Immuneering is a Buy
* Immuneering stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.